Deadline for Distinguished Scholar Award Applications Extended to October 15
September 16, 2014 – The Cooley’s Anemia Foundation is extending the application deadline for its first CAF-ApoPharma Distinguished Scholar Award to October 15, 2014.
The new scholarship program for is U.S. individuals with a clinically significant form of thalassemia who have chosen to pursue postgraduate doctoral level studies in medicine or science. The award is made possible through a grant from pharmaceutical manufacturer ApoPharma, which is providing the funds in recognition of the Foundation’s 60th anniversary.
CAF will award up to two scholarships to a U.S. citizen with a clinically significant form of thalassemia pursuing doctoral studies in biomedical sciences including medicine, pharmacy, nursing and basic research. (Ph.D., M.D., D.D.S., Pharm.D., D.V.M, etc.) in the United States or abroad. Total annual funding available for the awards is $20,000. Students enrolled in a doctoral program for the fall of 2014 are eligible to apply.
A clinically significant form of thalassemia would include alpha thalassemia major, beta thalassemia major, beta thalassemia intermedia, e beta thalassemia, hemoglobin H disease, or hemoglobin H disease-Constant Spring.
Applications must be received at CAF by the new deadline of October 15, 2014. There is not an application form; however, applicants should include all of the following information in their application:
- a personal statement of goals and professional objectives;
- a letter of reference from a member of the faculty in the program at the institution where the applicant is enrolled. If this is the applicant’s first year in the doctoral program, s/he may substitute a letter of recommendation from a member of the faculty at which undergraduate degree was obtained;
- a statement from patient’s treating physician confirming diagnosis as a thalassemia patient;
- a letter from bursar’s office of institution in which applicant is enrolled confirming applicant’s enrollment and including appropriate contact information for bursar’s office; and
- contact information (address, email and phone) for the applicant.
In addition, all applicants must be registered with the Cooley’s Anemia Foundation. (Applicants who are unsure if they are registered with the Foundation should contact CAF Patient Services Manager Eileen Scott at firstname.lastname@example.org).
Patients can apply via email or regular mail. Email applications should be sent tomailto:email@example.com with the subject line “Distinguished Scholarship Application.” Those sending in applications via regular mail should address them to:
Scholarship Review Committee
Cooley’s Anemia Foundation
330 Seventh Avenue, Suite 200
New York, NY 10001
All applications will be reviewed by a diverse panel which may request additional information from applicants.
Funding will be provided directly to the institution in which the applicant is enrolled.
Awards will be announced in November 2014. Applicants may apply annually for an award, granting of which is subject to availability of funds.
Questions concerning the CAF-ApoPharma Distinguished Scholar Award may be sent to firstname.lastname@example.org.